236 related articles for article (PubMed ID: 24260322)
21. [Effect of extracellular signal-regulated kinas 1/2 expression and HPV16 infection and their interaction in progression of cervical cancerization].
Fan SL; Ding L; Ren ZY; Chen X; Sun XS; Li CC; Liu CL; Jia WL; Li QL; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):96-101. PubMed ID: 28100386
[No Abstract] [Full Text] [Related]
22. Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
Guleria C; Suri V; Kapoor R; Minz RW; Aggarwal R
Gynecol Oncol; 2019 Oct; 155(1):151-160. PubMed ID: 31375269
[TBL] [Abstract][Full Text] [Related]
23. C13orf18 and C1orf166 (MULAN) DNA genes methylation are not associated with cervical cancer and precancerous lesions of human papillomavirus genotypes in Iranian women.
Sohrabi A; Mirab-Samiee S; Rahnamaye-Farzami M; Rafizadeh M; Akhavan S; Hashemi-Bahremani M; Modarresl MH
Asian Pac J Cancer Prev; 2014; 15(16):6745-8. PubMed ID: 25169519
[TBL] [Abstract][Full Text] [Related]
24. Genetic variants of the dUTPase-encoding gene DUT increase HR-HPV infection rate and cervical squamous cell carcinoma risk.
Ye F; Wang H; Liu J; Cheng Q; Chen X; Chen H
Sci Rep; 2019 Jan; 9(1):513. PubMed ID: 30679536
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women.
Lin ZH; Shen XH; Jin Z; Kim Y; Lee E; Kim H; Kim I
Pathol Int; 2005 Aug; 55(8):491-6. PubMed ID: 15998377
[TBL] [Abstract][Full Text] [Related]
26. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
Jiang B; Xue M
Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
[TBL] [Abstract][Full Text] [Related]
27. [Expression of epidermal growth factor receptor and the correlation with HPV16/18 infection in cervical intraepithelial neoplasia and cervical carcinoma].
Feng SY; Zhang YN; Liu JH; Liu JG; Yan M
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):759-63. PubMed ID: 18396688
[TBL] [Abstract][Full Text] [Related]
28. Tissue-based metabolomics reveals potential biomarkers for cervical carcinoma and HPV infection.
Abudula A; Rouzi N; Xu L; Yang Y; Hasimu A
Bosn J Basic Med Sci; 2020 Feb; 20(1):78-87. PubMed ID: 31465717
[TBL] [Abstract][Full Text] [Related]
29. An association between human papillomavirus 16/18 deoxyribonucleic acid in peripheral blood with p16 protein expression in neoplastic cervical lesions.
Tsai HJ; Peng YW; Lin LY; Chou MC; Lee H; Chiou HL
Cancer Detect Prev; 2005; 29(6):537-43. PubMed ID: 16289504
[TBL] [Abstract][Full Text] [Related]
30. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
[TBL] [Abstract][Full Text] [Related]
31. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
32. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
[TBL] [Abstract][Full Text] [Related]
33. [Relationship between human papillomavirus 16 infection and the expression of p33(ING1b), human telomerase reverse transcriptase in cervical squamous cell carcinoma of Uygur female in Xinjiang Uygur Autonomous Region].
Mayinuer N; Liu F; Zhu KC; Dai JX; Ayeti S; Wang L; Kunduozi U
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):592-6. PubMed ID: 18051711
[TBL] [Abstract][Full Text] [Related]
34. Distribution of human papillomavirus genotypes in archival cervical lesions in eastern inner Mongolian autonomous region, China.
Wu EQ; Yu XH; Zha X; Zhang GN; Wang JH; Fan Y; Tang YY; Zhao ZX; Wu YG; Kong W
Int J Gynecol Cancer; 2009 Jul; 19(5):919-23. PubMed ID: 19574785
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between TAP gene promoter methylation and cervical lesions with HPV infection in Uyghur women].
Aikuer G; Jiao Z; Wu XC; Ma JQ; Abudla A; Hasim A
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):438-42. PubMed ID: 22932452
[TBL] [Abstract][Full Text] [Related]
36. miR-106a Regulates Cell Proliferation and Autophagy by Targeting LKB1 in HPV-16-Associated Cervical Cancer.
Cui X; Wang X; Zhou X; Jia J; Chen H; Zhao W
Mol Cancer Res; 2020 Aug; 18(8):1129-1141. PubMed ID: 32345599
[TBL] [Abstract][Full Text] [Related]
37. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
[TBL] [Abstract][Full Text] [Related]
38. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
[TBL] [Abstract][Full Text] [Related]
39. HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland.
Anderson LA; O'Rorke MA; Wilson R; Jamison J; Gavin AT;
J Med Virol; 2016 Jul; 88(7):1262-70. PubMed ID: 26680281
[TBL] [Abstract][Full Text] [Related]
40. Are the human papillomavirus genotypes different in cervical cancer and intraepithelial neoplasia in Jewish Israeli women, a low-risk population?
Laskov I; Grisaru D; Efrat G; Trejo LL; Grisaru G; Avidor B
Int J Gynecol Cancer; 2013 May; 23(4):730-4. PubMed ID: 23446379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
